» Articles » PMID: 23209041

A Cost Evaluation of Peritoneal Dialysis and Hemodialysis in the Treatment of End-stage Renal Disease in Sao Paulo, Brazil

Overview
Journal Perit Dial Int
Publisher Sage Publications
Date 2012 Dec 5
PMID 23209041
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Conventional hemodialysis (HD) predominates over peritoneal dialysis (PD) around the world. Prospective and comparative studies comparing the costs of these modalities are scarce. In the present prospective assessment, we describe the resources used and total patient costs for both HD and PD. ♢

Methodology: We assessed 249 patients on HD and 228 on PD. All patients were 18 years of age or older and on stable dialysis. The information was collected at three points over 1 year, using standard questionnaires. The sources for costs were the Brazilian public and private health care systems. Societal perspective was considered. ♢

Statistical Analysis: Core trends and dispersions were measured. Regression models assessed the impact of modality on the average total cost per patient per year. ♢

Results: Of the 249 HD patients and 228 PD dialysis patients, 189 (74%) and 160 (70%) respectively completed follow-up. The mean age for women was 55.8 years; for men, it was 59.8 years (p = 0.001). The average total cost per patient-year was US$28 570 for HD and US$27 158 for PD. By category, the costs consisted of direct medical-hospital costs (82.3% for HD, 86.5% for PD), direct nonmedical costs (5.3% for HD, 3.7% for PD), and indirect costs (12.4% for HD, 9.8% for PD). Overall costs were less for PD patients than for their HD counterparts (p = 0.025). ♢

Conclusions: Maintenance dialysis represented the most important source of costs for both modalities; loss of productivity incurred significant costs. Future studies should contemplate the social consequences arising from each modality.

Citing Articles

Peritoneal dialysis: why not?.

Andreoli M, Totoli C, Rocha D, Campagnaro L J Bras Nefrol. 2023; 45(1):1-2.

PMID: 37015051 PMC: 10139715. DOI: 10.1590/2175-8239-JBN-2023-E001en.


Characteristics and 1-year survival of incident patients on chronic peritoneal dialysis compared with hemodialysis:a large 11-year cohort study.

Lima H, Nerbass F, Lugon J, Sesso R Int Urol Nephrol. 2023; 55(8):2025-2033.

PMID: 36809641 DOI: 10.1007/s11255-023-03489-1.


The direct cost of dialysis supported by families for patients with chronic renal failure in Ouagadougou (Burkina Faso).

Toure A, Balde M, Diallo A, Camara S, Soumah A, Sall A BMC Nephrol. 2022; 23(1):222.

PMID: 35739468 PMC: 9219226. DOI: 10.1186/s12882-022-02847-y.


Comparative analysis of patients' survival on hemodialysis vs. peritoneal dialysis and identification of factors associated with death.

Vicentini C, Ponce D J Bras Nefrol. 2022; 45(1):8-16.

PMID: 35510838 PMC: 10139729. DOI: 10.1590/2175-8239-JBN-2021-0242en.


Global Dialysis Perspective: Brazil.

Sesso R, Lugon J Kidney360. 2022; 1(3):216-219.

PMID: 35368628 PMC: 8809253. DOI: 10.34067/KID.0000642019.


References
1.
Blake P, Floyd J, Spanner E, Peters K . How much extra does "adequate" peritoneal dialysis cost?. Perit Dial Int. 1996; 16 Suppl 1:S171-5. View

2.
Sennfalt K, Magnusson M, Carlsson P . Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis. Perit Dial Int. 2002; 22(1):39-47. View

3.
Pacheco A, Saffie A, Torres R, Tortella C, Llanos C, Vargas D . Cost/Utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int. 2007; 27(3):359-63. View

4.
Kirby L, Vale L . Dialysis for end-stage renal disease. Determining a cost-effective approach. Int J Technol Assess Health Care. 2001; 17(2):181-9. DOI: 10.1017/s0266462300105045. View

5.
Neil N, Walker D, Sesso R, Blackburn J, Tschosik E, Sciaraffia V . Gaining efficiencies: resources and demand for dialysis around the globe. Value Health. 2008; 12(1):73-9. DOI: 10.1111/j.1524-4733.2008.00414.x. View